Mapping of liver fat with triple-echo gradient echo imaging: Validation against 3.0-T proton MR spectroscopy

European Radiology

Volumn 19, Issue 7, 2009, Pages 1786-1793

  Guiu, Boris ^a   Loffroy, Romaric ^a   Petit, Jean Michel ^a   Aho, Serge ^a   Ben Salem, Douraied ^a   Masson, David ^b   Hillon, Patrick ^a   Cercueil, Jean Pierre ^a   Krause, Denis ^a  

^a HÔPITAL DU BOCAGE   (France)

^b Chu   (France)

Author keywords

Fat quantification; Liver fat; Magnetic resonance spectroscopy; Mapping

Indexed keywords

CARBENE; WATER;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL TRIAL; DIFFUSION WEIGHTED IMAGING; FAT CONTENT; FEMALE; HUMAN; LIPID ANALYSIS; LIVER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; VALIDATION STUDY; VISUAL ORIENTATION;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ECHO-PLANAR IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 67349091088     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1330-9     Document Type: Article

References (42)

1. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, Rizzetto M (2002) Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123:134-140
2. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH (2004) Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 40:1387-1395
3. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:E462-E468
4. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, Tiribelli C (2000) Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132:112-117
5. Targher G, Bertolini L, Rodella S, Tessari R, Zenari L, Lippi G, Arcaro G (2007) Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 30:2119-2121
6. Johnson NA, Walton DW, Sachinwalla T, Thompson CH, Smith K, Ruell PA, Stannard SR, George J (2008) Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders. Hepatology 47:1513-1523
7. Cowin GJ, Jonsson JR, Bauer JD, Ash S, Ali A, Osland EJ, Purdie DM, Clouston AD, Powell EE, Galloway GJ (2008) Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging 28:937-945
8. Guiu B, Petit JM, Loffroy R, Ben Salem D, Aho S, Masson D, Hillon P, Krause D, Cercueil JP (2009) Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 250:95-102
9. Kim H, Taksali SE, Dufour S, Befroy D, Goodman TR, Petersen KF, Shulman GI, Caprio S, Constable RT (2008) Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL. Magn Reson Med 59:521-527
10. Reeder SB, Hargreaves BA, Yu H, Brittain JH (2005) Homodyne reconstruction and IDEAL water-fat decomposition. Magn Reson Med 54:586-593
11. Browning JD (2006) Statins and hepatic steatosis: Perspectives from the Dallas Heart Study. Hepatology 44:466-471
12. Irwan R, Edens MA, Sijens PE (2008) Assessment of the variations in fat content in normal liver using a fast MR imaging method in comparison with results obtained by spectroscopic imaging. Eur Radiol 18:806-813
13. Korenblat KM, Fabbrini E, Mohammed BS, Klein S (2008) Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 134:1369-1375
14. Kotronen A, Juurinen L, Hakkarainen A, Westerbacka J, Corner A, Bergholm R, Yki-Jarvinen H (2008) Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects. Diabetes Care 31:165-169
15. Machann J, Thamer C, Schnoedt B, Stefan N, Haring HU, Claussen CD, Fritsche A, Schick F (2006) Hepatic lipid accumulation in healthy subjects: A comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med 55:913-917
16. O'Regan DP, Callaghan MF, Wylezinska-Arridge M, Fitzpatrick J, Naoumova RP, Hajnal JV, Schmitz SA (2008) Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T-feasibility. Radiology 247:550-557
17. Jansen JF, Backes WH, Nicolay K, Kooi ME (2006) 1H MR spectroscopy of the brain: Absolute quantification of metabolites. Radiology 240:318-332
18. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D (2001) Java-based graphical user interface for the MRUI quantitation package. Magma 12:141-152
19. Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310
20. Lin LI (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics 45:255-268
21. de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC (2004) MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: Preliminary results. Radiology 230:652-659
22. Hussain HK, Chenevert TL, Londy FJ, Gulani V, Swanson SD, McKenna BJ, Appelman HD, Adusumilli S, Greenson JK, Conjeevaram HS (2005) Hepatic fat fraction: MR imaging for quantitative measurement and display-early experience. Radiology 237:1048-1055
23. Alustiza JM, Castiella A (2008) Liver fat and iron at in-phase and opposed-phase MR imaging. Radiology 246:641
24. Westphalen AC, Qayyum A, Yeh BM, Merriman RB, Lee JA, Lamba A, Lu Y, Coakley FV (2007) Liver fat: Effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology 242:450-455
25. Guiu B, Loffroy R, Cercueil JP, Krause D (2008) Multiecho MR imaging and proton MR spectroscopy for liver fat quantification. Radiology 249:1081
26. Bydder M, Yokoo T, Hamilton G, Middleton MS, Chavez AD, Schwimmer JB, Lavine JE, Sirlin CB (2008) Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 26:347-359
27. Mehta SR, Thomas EL, Bell JD, Johnston DG, Taylor-Robinson SD (2008) Non-invasive means of measuring hepatic fat content. World J Gastroenterol 14:3476-3483
28. Park SH, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW, Ha HK, Lee MG, Hwang S, Lee SG, Yu ES, Cho EY (2006) Macrovesicular hepatic steatosis in living liver donors: Use of CT for quantitative and qualitative assessment. Radiology 239:105-112
29. Fischbach F, Schirmer T, Thormann M, Freund T, Ricke J, Bruhn H (2008) Quantitative proton magnetic resonance spectroscopy of the normal liver and malignant hepatic lesions at 3.0 Tesla. Eur Radiol 18(11):2549-2558
30. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O (1994) Quantification of liver fat using magnetic resonance spectroscopy. Magnetic resonance imaging 12:487-495
31. Kim SH, Lee JM, Han JK, Lee JY, Lee KH, Han CJ, Jo JY, Yi NJ, Suh KS, Shin KS, Jo SY, Choi BI (2006) Hepatic macrosteatosis: Predicting appropriateness of liver donation by using MR imaging-correlation with histopathologic findings. Radiology 240:116-129
32. Borra RJ, Salo S, Dean K, Lautamaki R, Nuutila P, Komu M, Parkkola R (2009) Nonalcoholic fatty liver disease: Rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging. Radiology 250:130-136
33. Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA (2007) Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 133:496-506
34. Lautamaki R, Borra R, Iozzo P, Komu M, Lehtimaki T, Salmi M, Jalkanen S, Airaksinen KE, Knuuti J, Parkkola R, Nuutila P (2006) Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 291:E282-E290
35. Qayyum A, Goh JS, Kakar S, Yeh BM, Merriman RB, Coakley FV (2005) Accuracy of liver fat quantification at MR imaging: Comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques-initial experience. Radiology 237:507-511
36. Iannaccone R, Piacentini F, Murakami T, Paradis V, Belghiti J, Hori M, Kim T, Durand F, Wakasa K, Monden M, Nakamura H, Passariello R, Vilgrain V (2007) Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: Helical CT and MR imaging findings with clinical-pathologic comparison. Radiology 243:422-430
37. Stark DD, Wittenberg J, Middleton MS, Ferrucci JT (1986) Liver metastases: Detection by phase-contrast MR imaging. Radiology 158:327-332
38. Safanda J, Fakan F (1981) Histochemical and biochemical observations of the spleen in atypical Niemann-Pick disease and in idiopathic thrombocytopenic purpura. Acta Histochem 68:164-175
39. Yu JS, Chung JJ, Kim JH, Kim KW (2007) Fat-containing nodules in the cirrhotic liver: Chemical shift MRI features and clinical implications. AJR Am J Roentgenol 188:1009-1016
40. Yu JS, Park JG, Jeong EK, Park MS, Kim KW (2007) Hepatic MRI using the double-echo chemical shift phase-selective gradient-echo technique. AJR Am J Roentgenol 188:W49-W56
41. Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, Bass NM (2006) Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 44:874-880
42. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128:1898-1906